Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$8.41 USD
-0.18 (-2.10%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $8.43 +0.02 (0.24%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Recursion Pharmaceuticals, Inc. [RXRX]
Reports for Purchase
Showing records 81 - 86 ( 86 total )
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Machine Learning Advances New Rare Disease Research Forward
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are initiating coverage of RXRX with an Overweight rating
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D